Measurement of parathyroid hormone by radioimmunoassay and its clinical applications. 1979

G C Isaia, and L Castaldello, and A Thea, and G M Molinatti

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007011 Hypoparathyroidism A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone. Idiopathic Hypoparathyroidism,Hypoparathyroidism, Idiopathic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
January 1974, Review of surgery,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
May 1971, The American journal of medicine,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
December 1969, Clinical science,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
January 1973, Annales d'endocrinologie,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
January 1976, The Journal of nuclear biology and medicine,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
November 1981, Horumon to rinsho. Clinical endocrinology,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
November 1979, Horumon to rinsho. Clinical endocrinology,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
January 1975, Annals of clinical and laboratory science,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
June 1971, Nihon Naibunpi Gakkai zasshi,
G C Isaia, and L Castaldello, and A Thea, and G M Molinatti
March 1996, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!